Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TLR4 | O00206 | 2/20 | 0.31 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.30 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7505717 | 0.95 | CYP1A2 (0.35) | CYP1A2TLR4LMNAMAPK1HTT | |
| SCHEMBL17614834 | 0.90 | CYP1A2 (0.31) | CYP1A2CES2LPAR1LPAR3 | |
| SCHEMBL7504973 | 0.87 | TLR4 (0.33) | TLR4 | |
| SCHEMBL17614825 | 0.84 | CYP1A2 (0.31) | CYP1A2 | |
| SCHEMBL7516462 | 0.82 | TLR4 (0.34) | CYP1A2TLR4 | |
| SCHEMBL17614837 | 0.81 | CYP1A2 (0.39) | CYP1A2LMNAMAPK1HTT | |
| SCHEMBL17614847 | 0.79 | CYP1A2 (0.45) | CYP1A2LMNAMAPK1HTT | |
| SCHEMBL9151186 | 0.77 | TLR4 (0.36) | CYP1A2TLR4 | |
| SCHEMBL6058639 | 0.77 | TLR4 (0.36) | CYP1A2TLR4 | |
| SCHEMBL9416793 | 0.77 | CYP1A2 (0.50) | CYP1A2TLR4GNAO1LMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9580652-B2 | Liquid crystal compound, liquid crystal composition including the same and liquid crystal display including the liquid crystal composition | SAMSUNG DISPLAY CO., LTD. (KR) | 2017-02-28 | — | — | US | disclosed |
| US-20160083654-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY COMPRISING THE LIQUID CRYSTAL COMPOSITION | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-24 | — | — | US | disclosed |
| US-20160083653-A1 | LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION INCLUDING THE SAME AND LIQUID CRYSTAL DISPLAY INCLUDING THE LIQUID CRYSTAL COMPOSITION | SAMSUNG DISPLAY CO., LTD. (KR) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083654-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY COMPRISING THE LIQUID CRYSTAL COMPOSITION | NAP1L1, SLFN12, RCC2 | CYP1A2 660/4885TLR4 4448/4885GNAO1 1517/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.